Klotho Neurosciences, Inc.
KLTO
$0.1748
-$0.0069-3.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.50% | 625.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.50% | 625.71% | |||
| Operating Income | 35.50% | -625.71% | |||
| Income Before Tax | 30.14% | -555.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.14% | -555.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.14% | -555.31% | |||
| EBIT | 35.50% | -625.71% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 57.19% | -515.63% | |||
| Normalized Basic EPS | 57.13% | -515.56% | |||
| EPS Diluted | 57.83% | -525.00% | |||
| Normalized Diluted EPS | 57.13% | -515.56% | |||
| Average Basic Shares Outstanding | 63.12% | 6.44% | |||
| Average Diluted Shares Outstanding | 63.12% | 6.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||